FNY Investment Advisers’s Texas Capital Bancshares 5.75% Series B Preferred Stock TCBIO Stock Holding History

FNY Investment Advisers’s Portfolio TCBIO Stock Details TCBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-462	Closed	-$9	–	798
2024 Q1	$9	Buy	+462	New	+$9.12K	0.01%	466

FNY Investment Advisers's TCBIO Position: Q2 2024 in Review

FNY Investment Advisers sold out of Texas Capital Bancshares 5.75% Series B Preferred Stock (TCBIO) in Q2 2024, closing a stake of 462 shares — an estimated $9 sold.

FNY Investment Advisers first reported a position in TCBIO in Q1 2024 and held it in 1 quarter. The position peaked at $9 in Q1 2024. 0 funds tracked by Wall St. Rank hold TCBIO as of Q2 2024.

FNY Investment Advisers reported no remaining Texas Capital Bancshares 5.75% Series B Preferred Stock position as of Q2 2024 after selling out during the quarter.
FNY Investment Advisers sold 462 Texas Capital Bancshares 5.75% Series B Preferred Stock shares in Q2 2024, an estimated $9.
FNY Investment Advisers first reported a position in Texas Capital Bancshares 5.75% Series B Preferred Stock in Q1 2024 and held it in 1 quarter.
FNY Investment Advisers's Texas Capital Bancshares 5.75% Series B Preferred Stock position peaked at $9 in Q1 2024.
0 funds tracked by Wall St. Rank held Texas Capital Bancshares 5.75% Series B Preferred Stock as of Q2 2024.

Based on FNY Investment Advisers's 13F filing for Q2 2024, filed 5 Aug 2024.